A New Nonsense Mutation of the IGHMBP2 Gene Responsible for the First Case of SMARD1 in a Sardinian Patient with Giant Cell Hepatitis

Abstract

We describe the case of a Sardinian female child affected by SMARD1, a genetic composite heterozygote, in whom a new nonsense mutation (R788X) was found. A sister was affected by generalized muscular hypotonia and died from respiratory insufficiency at the age of 9 months, before a diagnostic definition had been formulated. Our patient died at 6 months due to respiratory insufficiency. At autopsy some differences with previous published cases were observed. In fact, our case is to the best of our knowledge the first report of giant cell hepatitis and myocarditis in SMARD1-affected patients, although this could be a chance association.

Key words

SMARD1 - child - gene mutation

References

• 1 Campbell Jr LV, Gilbert EF. Experimental giant cell transformation in the liver induced by E. coli endotoxin.  Am J Pathol. 1967;  51 855-864
• 2 Dick MC, Mowat AP. Hepatitis syndrome in infancy-an epidemiological survey with 10 year follow-up.  Arch Dis Child. 1985;  60 512-516
• 3 Fukita Y, Mizuta TR, Shirozu M. The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region.  J Biol Chem. 1993;  268 17463-17470
• 4 Grishin NV. The R3H motif: A domain that binds single-stranded nucleic acids.  Trends Biochem Sci. 1998;  23 329-330
• 5 Grohmann K, Rossol W, Kobsar I. et al . Characterization of IGHMBP2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).  Hum Mol Genet. 2004;  13 2031-2042
• 6 Grohmann K, Schuelke M, Diers A. et al . Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.  Nature Genet. 2001;  29 75-77
• 7 Grohmann K, Varon R, Stolz P. et al . Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).  Ann Neurol. 2003;  54 719-724
• 8 Guenther UP, Varon R, Schlicke M. et al . Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): Defining novel phenotypes through hierarchical cluster analysis.  Hum Mutat. 2007;  28 808-815
• 9 Kaindl AM, Guenther UP, Rudnik-Schöneborn S. et al . Spinal muscular atrophy with respiratory distress type 1 (SMARD1).  J Child Neurol. 2008;  23 199-204
• 10 Maddatu TP, Garvey SM, Schroeder DG. et al . Dilated cardiomyopathy (DCM) in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival.  Hum Mol Genet. 2005;  14 3179-3189
• 11 Maystadt I, Zarhrate M, Landrieu P. et al . Allelic heterogeneity of SMARD1 at the IGHMBP2 locus.  Human Mutation. 2004;  23 719-724
• 12 Mizuta TR, Fukita Y, Miyoshi T. et al . Isolation of cDNA encoding a binding protein specific to 5′-phosphorylated single-stranded DNA with G-rich sequences.  Nucleic Acids Res. 1993;  21 1761-1666
• 13 Mohan U, Misra VP, Britto J. et al . Inherited early onset severe axonal polyneuropathy with respiratory failure and autonomic involvement.  Neuromuscular Disord. 2001;  11 395-399
• 14 Nobutada T, Sin K, Naoki K. et al . A new mutation of IGHMBP2 gene in spinal muscular atrophy with respiratory distress type 1.  Pediatric Neurology. 2005;  32 288-290
• 15 Oiedzka-Slotwinska ZZ, Desmet VJ. Morphologie neonatal liver “Giant” cell transformation.  Exp Mol Biol. 1969;  10 162-175
• 16 Pitt M, Houlden H, Jacobs J. et al . Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1.  Brain. 2003;  126 2682-2692
• 17 Wilmshurst JM, Bye A, Rittey C. et al . Severe infantile axonal neuropathy with respiratory failure.  Muscle Nerve. 2001;  24 760-768
• 18 Wong VCN, Chung B, Li S. et al . Mutation of gene in spinal muscular atrophy respiratory distress type 1.  Pediatric Neurology. 2006;  34 474-477

Correspondence